Compound Detail
CHEMBL70663
DAPIVIRINE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL70663 |
| Name | DAPIVIRINE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | ILAYIAGXTHKHNT-UHFFFAOYSA-N |
8
Targets
126
Activities
2
Assay Types
2
PK Parameters
20
Publications
7
Known Names
4
Indications
1
Mechanisms
Molecular Properties
329.4
MW (Da)
4.76
ALogP
5
HBA
2
HBD
73.6
PSA (Ų)
0.72
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase inhibitor | INHIBITOR | Human immunodeficiency virus type 1 reverse transcriptase | ✓ | ✓ |
Indications
HIV Infections HIV Infections Acquired Immunodeficiency Syndrome Infections
ATC Classification
G01AX17
dapivirine
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
Activity Summary
EC50 75 meas. best 10.98
IC50 51 meas. best 10.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 10.98 | 8.3297 | 0.0 | 64 |
| Human immunodeficiency virus 1 CHEMBL378 | IC50 | 10.0 | 8.7739 | 0.1 | 28 |
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | IC50 | 9.0 | 7.0159 | 1.0 | 17 |
| MT4 CHEMBL388 | EC50 | 9.0 | 7.9883 | 1.0 | 6 |
| Unchecked CHEMBL612545 | IC50 | 6.39 | 6.355 | 404.0 | 2 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 6.14 | 6.14 | 730.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 5.9 | 5.9 | 1250.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.31 | 5.31 | 4880.0 | 1 |
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 4.71 | 4.71 | 19500.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 19400.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 4700.0 | ng.hr.mL-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19029331 | 10.1128/aac.01156-08 | Human immunodeficiency virus 1 | 76 |
| 24805780 | 10.1021/jm500139a | Human immunodeficiency virus 1 | 23 |
| 19258271 | 10.1128/aac.01096-08 | Human immunodeficiency virus 1 | 13 |
| 30525601 | 10.1021/acs.jmedchem.8b01238 | Human immunodeficiency virus 1 | 11 |
| 23084903 | 10.1016/j.bmcl.2012.09.066 | Human immunodeficiency virus 1 | 10 |
| 19704127 | 10.1128/aac.00800-09 | Human immunodeficiency virus 1 | 9 |
| 21438533 | 10.1021/jm101626c | Human immunodeficiency virus 1 | 9 |
| 11527705 | 10.1016/s0960-894x(01)00412-7 | Human immunodeficiency virus 1 | 7 |
| 30223123 | 10.1016/j.ejmech.2018.09.013 | Human immunodeficiency virus type 1 reverse transcriptase | 7 |
| 15771411 | 10.1021/jm040127p | MT4 | 7 |
| 22428851 | 10.1021/jm201308v | Human immunodeficiency virus 1 | 7 |
| 15771434 | 10.1021/jm040840e | Human immunodeficiency virus 1 | 7 |
| 15115397 | 10.1021/jm030558s | Human immunodeficiency virus 1 | 7 |
| 19029331 | 10.1128/aac.01156-08 | Unchecked | 6 |
| 22428851 | 10.1021/jm201308v | Human immunodeficiency virus type 1 reverse transcriptase | 6 |
| 21930388 | 10.1016/j.bmc.2011.08.060 | Human immunodeficiency virus 1 | 6 |
| 23937980 | 10.1016/j.bmcl.2013.06.091 | Human immunodeficiency virus 1 | 6 |
| 19704127 | 10.1128/aac.00800-09 | Human immunodeficiency virus type 1 reverse transcriptase | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 6 |
| 21438533 | 10.1021/jm101626c | Human immunodeficiency virus type 1 reverse transcriptase | 5 |
Data from ChEMBL 36 via Core Engine